ZINFORO®

CAP, community-acquired pneumonia; cSSTI, complicated skin and soft tissue infection; MOA, mode of action.

References
1. ZINFORO® (ceftaroline fosamil). Local Product Document of Ceftaroline. LPDZIN072021. 
2. Rosanova MT, et al. Ther Adv Infect Dis. 2019;6:2049936118808655.
3. Garrison MW, et al. Expert Rev Anti Infect Ther. 2012;10:1087-1103.

 

PP-ZFO-IND-0416 13 June 2022
Please click on Prescribing Information link to view safety and adverse events information of Zinforo.
For the use only of registered medical practitioners, or a hospital or a laboratory.